Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Onderzoeksoutput
-
Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis
Zhou, G., de Vos, S., Schuiling-Veninga, C., Bos, J., Oude Rengerink, K., Pasmooij, M., Mol, P. G. M., de Bock, G. H. & Hak, E., 27-jul.-2023, In: Clinical epidemiology. 15, blz. 923-937 15 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand1 Downloads (Pure) -
Contribution of Real-World Evidence in European Medicines Agency's Regulatory Decision Making
Bakker, E., Plueschke, K., Jonker, C. J., Kurz, X., Starokozhko, V. & Mol, P. G. M., jan.-2023, In: Clinical Pharmacology & Therapeutics. 113, 1, blz. 135-151 17 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand9 Citaten (Scopus)30 Downloads (Pure) -
Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish heart failure registry
Becher, P. M., Savarese, G., Benson, L., Dahlström, U., Karlström, P., Mol, P. G. M., Metra, M., Bhatt, D. L., Pitt, B. & Lund, L. H., 1-jun.-2023, In: European Heart Journal - Cardiovascular Pharmacotherapy. 9, 4, blz. 343-352 10 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand9 Downloads (Pure) -
Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis
Zhou, G., Verweij, S., Bijlsma, M. J., de Vos, S., Oude Rengerink, K., Pasmooij, A. M. G., van Baarle, D., Niesters, H. G. M., Mol, P., Vonk, J. M. & Hak, E., 28-aug.-2023, In: BMJ open respiratory research. 10, 1, 12 blz., e001674.Onderzoeksoutput › Academic › peer review
Open AccessBestand1 Downloads (Pure) -
Safety-Related Drug Label Changes Following Large Post-Marketing Cardiometabolic Trials: A Review of European Public Assessment Reports
Starokozhko, V., Tarrahi, F., Vrijlandt, P. J. W. S. & Mol, P. G. M., apr.-2023, In: Clinical Pharmacology and Therapeutics. 113, 4, blz. 859-866 8 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand14 Downloads (Pure)
Activiteiten
-
Strengthening Training for Academia in Regulatory Science (STARS) Project: The road so far
Peter Mol (Speaker)
mrt.-2022Activiteit: Academic presentation › Academic
-
A Selective Approach to Safety Data Collection in Specific Late-Stage Pre-approval or Post-Approval Clinical Trials
Peter Mol (Speaker)
apr.-2022Activiteit: Professional or public presentation › Professional
-
The patient voice in drug regulation; a European regulator’s perspective on patient preference studies
Peter Mol (Speaker)
apr.-2022Activiteit: Academic presentation › Academic
-
PhD project in the IMI European Platform for Neurodegenerative Diseases EPND project
Peter Mol (Other)
2022 → 2027Activiteit: Supervision and examination of PhD students of the UG › Academic
-
RWE en registraties in marketing authorization applications – wat is nou echt de impact op de besluitvorming?
Peter Mol (Speaker)
jun.-2022Activiteit: Professional or public presentation › Professional
Prijzen
-
Among the most popular scientific papers in Drug Safety 2019
de Vries, Sieta (Recipient), Mol, Peter (Recipient) & Denig, Petra (Recipient), 2019
Prijs: Other distinction › Academic
-
Nomination of Top downloaded paper 2018-2019 in BJCP
de Vries, Sieta (Recipient), Denig, Petra (Recipient), Mol, Peter (Recipient) & van Puijenbroek, Eugène (Recipient), 30-apr.-2019
Prijs: Other distinction › Academic
-
Among the most popular scientific papers in Drug Safety 2018
de Vries, Sieta (Recipient), Mol, Peter (Recipient) & Denig, Petra (Recipient), 2018
Prijs: Other distinction › Academic
-
Among the most popular publications in Drug Safety in 2017
de Vries, Sieta (Recipient) & Mol, Peter (Recipient), 2017
Prijs: Other distinction › Academic